Search Results - "Elisa Meddi"
-
1
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML
Published in International journal of molecular sciences (01-02-2023)“…In acute myeloid leukemia (AML) many patients experience relapse, despite the achievement of morphological complete remission; therefore, conventional…”
Get full text
Journal Article -
2
Preliminary identification of areas suitable for Sustainable Drainage Systems and Managed Aquifer Recharge to mitigate stormwater flooding phenomena in Rome (Italy)
Published in Acque Sotterranee (20-12-2022)“…This paper proposes a preliminary and large-scale survey methodology to identify areas suitable for indepth analysis for the application of Sustainable…”
Get full text
Journal Article -
3
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country
Published in Mediterranean journal of hematology and infectious diseases (29-06-2024)“…Identification of latent tuberculosis infection (LTBI) is a critical step of tuberculosis surveillance, especially in low-incidence countries. However, it is…”
Get full text
Journal Article -
4
Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior
Published in Mediterranean journal of hematology and infectious diseases (2022)“…T-cell lymphomas and leukemias are highly heterogeneous groups of rare disorders. We report a case of a 68-year-old man patient who developed two different…”
Get full text
Journal Article -
5
Real Life Feasibility of a Combined Clinical and Biological Fitness Assessment in Patients with Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
6
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)
Published in Leukemia (01-10-2024)Get full text
Journal Article -
7
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation
Published in Current research in translational medicine (01-09-2024)“…Sézary syndrome (SS) is a rare and aggressive T-cell lymphoma with a poor prognosis in advanced stages. Allogeneic hematopoietic cell transplantation…”
Get full text
Journal Article -
8
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia
Published in Thrombosis research (01-04-2024)“…Coagulation disorders frequently complicate the clinical course of acute myeloid leukemia (AML) patients. This study examined the frequency and prognostic…”
Get full text
Journal Article -
9
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge
Published in Current research in translational medicine (01-06-2024)“…We present the case of a young adult, who developed several hepatic post-HCT complications, which made differential diagnosis extremely difficult…”
Get full text
Journal Article -
10
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation
Published in Mediterranean journal of hematology and infectious diseases (01-09-2023)“…Therapy-related myeloid neoplasms (t-MNs) encompass a specific sub-group of myeloid malignancies arising after exposure to radio/cytotoxic agents for the…”
Get full text
Journal Article -
11
Optimal Prognostic Threshold for Acute Myeloid Leukemia (AML) Measurable Residual Disease (MRD) Positivity By Multiparameter Flow Cytometry: A Report of 2,051 Patients from MRC/NCRI, Gimema, HOVON, and Seattle
Published in Transplantation and cellular therapy (01-02-2024)“…The ELN MRD Working Party defines multiparameter flow cytometry (MFC)-based measurable residual disease (MRD) positivity for AML at the threshold of ≥0.1% of…”
Get full text
Journal Article -
12
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone: De novo polycythemia vera following AML remission
Published in Mediterranean journal of hematology and infectious diseases (29-06-2022)“…Evolution of myeloproliferative neoplasms (MPN) to acute myeloid leukemia (AML) occurs in 2-10% of patients, whereas the reverse path from AML to MPN has been…”
Get full text
Journal Article -
13
An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone
Published in Mediterranean journal of hematology and infectious diseases (01-07-2022)“…The evolution of myeloproliferative neoplasms (MPN) to acute myeloid leukemia (AML) occurs in 2–10% of patients, depending on the MPN subtype, treatment, and…”
Get full text
Journal Article -
14
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone
Published in Mediterranean journal of hematology and infectious diseases (01-06-2022)“…Evolution of myeloproliferative neoplasms (MPN) to acute myeloid leukemia (AML) occurs in 2-10% of patients, whereas the reverse path from AML to MPN has been…”
Get full text
Journal Article -
15
-
16